by Fed Up Texas Chick
Monkeypox is dominating the news cycle. Is it a Deep State distraction as their empire collapses, or should the citizens of the world be worried? What do we know right now? Let’s look at the timeline.
According to the US Centers for Disease Control and Prevention (CDC), monkeypox was first discovered in 1958. Two outbreaks of a pox-type disease occurred in a colony of research monkeys, hence the name ‘monkeypox.’ It was a rare disease caused by an Orthopoxvirus infection, from the same genus of viruses that cause smallpox and cowpox. While related to smallpox, monkeypox is a much milder skin infection. Most people recover in two to four weeks and the fatality rate is around 1 percent.
Human monkeypox cases have occurred outside of Africa and have been linked to international travel or to imported animals, including cases in the United States, Israel, Singapore, and the United Kingdom. The virus’ origin remains unknown but it is thought that monkeys and rodents carry the virus and can infect people.
The CDC reported the first human monkeypox infection was identified in the Democratic Republic of Congo (DRC) during the intensified effort to eliminate smallpox. Monkeypox in humans has only been reported on the African continent.
Fast forward forty years: The European Medicines Agency approves the live, attenuated vaccinia virus vaccine, JYNNEOS, for use against smallpox and monkeypox in Europe. In Canada, the vaccine was marketed as IMVAMUNE and in the UK, it was sold as IMVANEX. The company stated that the live virus in the vaccine is “incapable of replicating in the human body yet able to elicit a potent immune response.”
The FDA approves the JYNNEOS vaccine.
March 2021: A pandemic simulation exercise to reduce the global threat of monkeypox is held at the Munich Security Conference in March 2021. A nonprofit organization known as the Nuclear Threat Initiative (NTI) spearheaded the simulation exercises where an unusual strain of monkeypox was released by a terrorist organization. It spread globally and infected three billion people worldwide, leaving 270 million people dead.
NTI is a very influential global organization. Founded by Sam Nunn, a United States Senator (D) from Georgia (1972–1997). Nunn served as CEO until June 2017, until he became co-chair with Ted Turner and Ernest Moniz. Other prominent members of NTI included former California governor Gerry Brown, former US Ambassador Jon M. Huntsman, former FDA Commissioner Margaret A. Hamburg, and former head of the Joint Chiefs of Staff Admiral Michael T. Mullen.
February 2022: Nine researchers from the infamous Wuhan Institute of Virology published a paper outlining how the lab assembled the monkeypox virus genome. The study showed that researchers appeared to identify a portion of the monkeypox genome that enabled PCR tests to identify the virus by targeting the E9L DNA polymerase gene. The National Pulse broke the story on May 22, 2022.
March 2022: Health websites began reporting blistering at the injection site, a side effect of both AstraZeneca and Pfizer COVID-19 shots. Soon, cases reported widespread blistering on the legs, torso, back and even full body. Researchers begin publishing instances of autoimmune bullous diseases (AIBDs), a group of diseases characterized by blisters, including bullous pemphigoid (BP) and pemphigus. The researchers in this paper used a French pharmacovigilance method to show that the likelihood that the skin eruptions were triggered by the COVID-19 vaccine was high.
May 2022 – Acceleration of the Plan
May 2: Pfizer does another court-ordered data drop of test results and documents. On page 2 of the list of adverse events, it is discovered the jab can lead to autoimmune blistering disease.
May 12: The US DoD awarded a contract to SIGA Technologies to procure $7.5 million worth of smallpox drug oral TPOXX (tecovirimat), half of which is to be delivered in 2022.
TPOXX was approved by the UK and European health regulatory bodies around the same time SIGA Technologies was awarded the contract. A visit to SIGA’s home page shows the company touting their vaccine as “human bio-armor” while prominently displaying this quote from Bill Gates: “…the next epidemic could originate on the computer screen of a terrorist intent on using genetic engineering to create a synthetic version of the smallpox virus…”
Edison Group is the primary investor for SIGA. They also invest in many pharmaceutical companies and Blackrock entities. In fact, Blackrock and Vanguard are both major SIGA shareholders. Most notably, SIGA formed a partnership with Meridian Medical Technologies in 2019 regarding TPOXX, and Meridian has an interesting parent company. Yes, you guessed it – Pfizer.
May 15: The monkeypox outbreak starts in the exact same week as predicted by the NTI 2021 simulation. This substack by Michael P Senger gives a rundown of the simulated viral progression.
The UK began offering JYNNEOS (IMVANEX) to specific individuals. While only 56 cases were confirmed as of May 7, more than 1,000 vaccines had been administered, mainly to frontline health workers.
On May 17, seven cases of monkeypox were confirmed in the UK. Journal articles began surfacing, like this case study about a man traveling from Nigeria to Dallas with the disease. Although the travel happened in July 2021, the case was just now being published. No origin for the man’s disease could ever be found, and none of his close personal contacts ever became ill. Here is a similar case study about a traveler from Nigeria to Maryland.
May 18: The US Biomedical Advanced Research and Development Authority (BARDA) exercised the first option of a long-standing contract with Danish company Bavarian Nordic A/S to purchase the freeze-dried version of the JYNNEOS smallpox vaccine which has not yet been approved for use in the US. On May 20, 2022, the Biden administration ordered 13 million doses of the monkeypox vaccine after ONE Massachusetts man was found to be infected with monkeypox, a generally mild disease.
The CDC seems to be gearing up for monkeypox as well, issuing vaccine guidance stating that both JYNNEOS and another vaccine, ACAM2000, are licensed in the US to prevent smallpox. because monkeypox is so closely related to smallpox, the CDC would likely push both of these vaccines going forward into another ‘pandemic.’ ACAM2000 also contains a live vaccinia virus. VAERS reporting for the ACAM2000 began in 2009 as it was used on the military. It has a fairly significant list of adverse events.
May 19: The FDA approved SIGA’s intravenous TPOXX drug, seven days after the multi-million dollar DoD contract award. Available in pill form for several years, SIGA got approval to deliver it directly to your bloodstream via an IV.
When Canada reported 15 suspected cases and France reported its first suspected case, the European Centre for Disease Prevention and Control announced that most cases occurred in men who identify as MSM (men who have sex with men). None had recently traveled to endemic disease areas. Epidemiologists traced the outbreak to a recent gay pride festival held in Antwerp, Belgium between May 5 and 15. More than 80,000 people from across the world attended the event. The thing is, monkeypox is not as easily transmitted; it is not a respiratory virus. It is believed to have spread through skin-to-skin contact with someone with an active rash.
May 20: The US confirmed a case of monkeypox in Massachusetts and one case in New York. Australia confirmed two cases and issued a public health alert.
May 21: Switzerland reports its first case.
May 22: The World Health Assembly (WHA) meeting begins in Davos, Switzerland to consider amendments that, if they had passed, would have given the WHA unilateral control to intervene in the affairs of any nation deemed to have a health emergency. You can read more about the proposed treaty here. On the same day, Belgium announces a compulsory 21-day quarantine for anyone who tests positive for the monkeypox virus.
May 23: The US Food and Drug Administration (FDA) published its Smallpox Preparedness and Response Updates. The US government assures Americans that it has enough smallpox vaccine stored in its Strategic National Stockpile (SNS) to vaccinate the entire US population. The same day, Moderna Inc. stated they were investigating monkeypox vaccines (plural) at a preclinical level. As of May 23, there are fewer than 300 (260) cases worldwide, and many of those are unconfirmed in 19 countries (interestingly all NATO countries). In the US, four states – New York, Utah, Florida and Massachusetts — have confirmed cases to date. US public health officials maintain that the risk to the general public is low.
May 24: During their World Health Assembly in Geneva, the WHO says that the virus outbreak outside of Africa can be contained. During the meeting, many governments stated they would have limited vaccination campaigns, given that (a) there is not a vaccine for monkeypox (only for smallpox) and (b) there are only 237 total suspected and confirmed minor cases in 19 countries. Given the global population of 8 billion, officials feel the risks are low.
Or Could It Be Something Completely Different?
Credible scientists are concerned about the monkeypox cases because they originate in areas where people have never been exposed to the virus. Other scientists like Angela Rasmussen, a virologist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan in Canada, attributed the spread to global travel and climate change, saying the world is much more alert to new viral outbreaks after experiencing the COVID pandemic over the last four years.
Alexander says what we are seeing now in monkeypox is just the tip of the iceberg.
Buckle up. More coming soon.
Like what you’re reading on The Tenpenny Report? Share this article with your friends. Help us grow.
Fed Up Texas Chick is a contributing writer for The Tenpenny Report. She’s a rocket scientist turned writer, having worked in the space program for many years. She is a seasoned medical writer and researcher who is fighting for medical freedom for all of us through her work.